Page last updated: 2024-08-21

trinitrobenzenesulfonic acid and Graft vs Host Disease

trinitrobenzenesulfonic acid has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Estarreja, J; Mateus, V; Pinto, R; Silva, I1

Other Studies

1 other study(ies) available for trinitrobenzenesulfonic acid and Graft vs Host Disease

ArticleYear
Efficacy and safety of erythropoietin in a chronic model of Inflammatory Bowel Disease.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156

    Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Colitis; Erythropoietin; Graft vs Host Disease; Inflammatory Bowel Diseases; Mice; Trinitrobenzenesulfonic Acid

2022